You can find the annual or quarterly income statement of Immix Biopharma Inc here for insights into the performance and operational efficiency of Immix Biopharma Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2020Q4

FY2020Q3

Operating expenses

130.71%10.80M

118.43%10.89M

3.62%7.66M

42.85%6.72M

-16.23%4.68M

-7.23%4.99M

63.47%7.39M

26.39%4.70M

121.76%5.59M

41.67%5.38M

195.02%4.52M

138.36%3.72M

89.52%2.52M

534.19%3.79M

340.64%1.53M

--1.56M

--1.33M

289.57%598.34K

281.42%347.99K

--153.59K

--91.23K

R&D expenses

202.80%5.98M

316.70%5.73M

3.12%4.58M

78.61%3.97M

-39.20%1.98M

-55.68%1.37M

111.09%4.45M

0.67%2.22M

146.29%3.25M

37.05%3.10M

202.62%2.11M

263.51%2.21M

109.52%1.32M

24397.17%2.26M

2244.01%695.94K

--607.75K

--629.53K

-88.92%9.24K

-33.96%29.69K

--83.33K

--44.96K

Depreciation, depletion, and amortization

54.74%91.58K

26.07%52.11K

274.38%96.99K

140.77%58.49K

1866.11%59.18K

1243.86%41.34K

1775.89%25.91K

4701.38%24.30K

496.04%3.01K

443.46%3.08K

143.99%1.38K

32.11%506.00

-18.55%505.00

-8.71%566.00

--383.00

--620.00

6.71%620.00

6.90%620.00

--581.00

--580.00

Operating profit

-130.71%-10.80M

-118.43%-10.89M

-3.62%-7.66M

-42.85%-6.72M

16.23%-4.68M

7.23%-4.99M

-63.47%-7.39M

-26.39%-4.70M

-121.76%-5.59M

-41.67%-5.38M

-195.02%-4.52M

-138.36%-3.72M

-89.52%-2.52M

-534.19%-3.79M

-340.64%-1.53M

---1.56M

---1.33M

-289.57%-598.34K

-281.42%-347.99K

---153.59K

---91.23K

Net non-operating interest income (expenses)

Non-operating interest income

377.41%717.17K

16.61%216.71K

-67.06%84.54K

-66.10%104.06K

-43.93%150.22K

-18.69%185.85K

37.49%256.68K

138.20%306.92K

860.52%267.91K

--228.57K

--186.69K

--128.85K

--27.89K

----

Non-operating interest expense

----

--0.00

-100.00%0.00

--109.00

--388.00

80.26%44.51K

130.78%53.94K

--24.69K

--23.37K

Special income (expenses)

----

100.00%0.00

----

---86.17K

----

Other non-operating income (expenses)

----

100.00%0.00

--0.00

-3730.37%-22.02M

-100.00%0.00

---575.01K

--8.00

Income before tax

-122.53%-10.09M

-122.37%-10.68M

-6.16%-7.58M

-50.46%-6.61M

14.83%-4.53M

6.72%-4.80M

-64.59%-7.14M

-22.38%-4.40M

-113.50%-5.32M

-35.65%-5.15M

-182.85%-4.34M

-130.09%-3.59M

-87.37%-2.49M

83.32%-3.79M

-281.51%-1.53M

---1.56M

---1.33M

-2920.62%-22.75M

-250.73%-401.93K

---753.28K

---114.60K

Income tax

-100.00%0.00

4.46%11.27K

-30.71%7.72K

-13.20%8.91K

11.12%9.82K

33.33%10.79K

63.71%11.14K

61.74%10.27K

70.97%8.84K

53.81%8.09K

307.12%6.81K

270.20%6.35K

218.74%5.17K

256.06%5.26K

25.06%1.67K

--1.72K

--1.62K

-87.99%1.48K

-22.31%1.34K

--12.29K

--1.72K

Income after tax

-122.05%-10.09M

-122.11%-10.69M

-6.10%-7.59M

-50.31%-6.62M

14.79%-4.54M

6.66%-4.81M

-64.58%-7.15M

-22.45%-4.41M

-113.41%-5.33M

-35.67%-5.16M

-182.98%-4.34M

-130.24%-3.60M

-87.53%-2.50M

83.30%-3.80M

-280.66%-1.54M

---1.56M

---1.33M

-2872.31%-22.76M

-246.69%-403.26K

---765.58K

---116.32K

Net income from continuous operations

-122.05%-10.09M

-122.11%-10.69M

-6.10%-7.59M

-50.31%-6.62M

14.79%-4.54M

6.66%-4.81M

-64.58%-7.15M

-22.45%-4.41M

-113.41%-5.33M

-35.67%-5.16M

-182.98%-4.34M

-130.24%-3.60M

-87.53%-2.50M

83.30%-3.80M

-280.66%-1.54M

---1.56M

---1.33M

-2872.31%-22.76M

-246.69%-403.26K

---765.58K

---116.32K

Net Income attributable to non-controlling interests

----

--0.00

100.00%0.00

41.29%-12.91K

-292.38%-72.07K

---65.86K

---63.25K

---22.00K

---18.37K

----

Net income attributable to controlling interests

-122.05%-10.09M

-122.11%-10.69M

-6.10%-7.59M

-50.75%-6.62M

13.62%-4.54M

5.45%-4.81M

-67.02%-7.15M

-22.84%-4.39M

-112.08%-5.26M

-33.94%-5.09M

-178.86%-4.28M

-128.84%-3.58M

-86.15%-2.48M

83.30%-3.80M

-280.66%-1.54M

---1.56M

---1.33M

-2872.31%-22.76M

-246.69%-403.26K

---765.58K

---116.32K

Net income attributable to common shareholders

-122.05%-10.09M

-122.11%-10.69M

-6.10%-7.59M

-50.75%-6.62M

13.62%-4.54M

5.45%-4.81M

-67.02%-7.15M

-22.84%-4.39M

-112.08%-5.26M

-33.94%-5.09M

-178.86%-4.28M

-128.84%-3.58M

-86.15%-2.48M

83.30%-3.80M

-280.66%-1.54M

---1.56M

---1.33M

-2872.31%-22.76M

-246.69%-403.26K

---765.58K

---116.32K

Basic earnings per share

-19.11%-0.18

-63.24%-0.27

2.21%-0.24

-44.73%-0.22

31.84%-0.15

30.34%-0.16

-5.45%-0.24

35.82%-0.15

-25.75%-0.22

14.45%-0.23

-109.01%-0.23

-111.23%-0.24

-85.27%-0.18

91.36%-0.27

-96.82%-0.11

---0.11

---0.10

-2872.31%-3.16

-246.60%-0.06

---0.11

---0.02

Diluted earnings per share

-19.11%-0.18

-63.24%-0.27

2.21%-0.24

-44.73%-0.22

31.84%-0.15

30.34%-0.16

-5.45%-0.24

35.82%-0.15

-25.75%-0.22

14.45%-0.23

-109.01%-0.23

-111.23%-0.24

-85.27%-0.18

91.36%-0.27

-96.82%-0.11

---0.11

---0.10

-2872.31%-3.16

-246.60%-0.06

---0.11

---0.02

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

